Stay updated on FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial page.

Latest updates to the FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial page
- Check7 days agoChange DetectedThe page revision has been updated from v3.5.4 to v3.5.5, indicating a backend or display update. It does not modify the study content or user-facing functionality beyond metadata.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page revision label was updated from v3.5.3 to v3.5.4, indicating an internal update to the study record page. There is no indication that substantive study details were changed.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page revision indicator has been updated from **Revision v3.5.2** to **Revision v3.5.3**. A glossary/term display for **“Idiopathic Pulmonary Fibrosis”** is present, without altering the study’s substantive details.SummaryDifference0.1%

- Check57 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check78 days agoChange DetectedRemoved the keyword 'Interstitial lung disease 2' from the page metadata/keywords.SummaryDifference0.1%

- Check86 days agoChange DetectedSite version updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial page.